Amicus Therapeutics Inc. logo

Amicus Therapeutics Inc. (FOLD)

Market Closed
5 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
9. 90
-0.05
-0.5%
$
3.09B Market Cap
- P/E Ratio
0% Div Yield
3,386,792 Volume
-0.45 Eps
$ 9.95
Previous Close
Day Range
9.79 10.05
Year Range
5.51 10.57
Want to track FOLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 73 days
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
18 Feb 2026 (In 2 months)
0.14
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
5 Nov 2025
0.02
Cons. EPS
0.17
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
4 Nov 2025
0.12
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
31 Jul 2025
-
Cons. EPS
0.01
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
7 May 2025
-
Cons. EPS
0.03
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
26 Feb 2025
0.09
Cons. EPS
0.09
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
6 Nov 2024
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
6 Aug 2024
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
9 May 2024
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
28 Feb 2024
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
6 Nov 2023
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
7 Nov 2016
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
9 Aug 2016
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
3 May 2016
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
26 Feb 2016
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
3 Nov 2015
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
5 Aug 2015
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
5 May 2015
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
3 Mar 2015
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
6 Nov 2014
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
7 Aug 2014
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
5 May 2014
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
3 Mar 2014
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
12 Nov 2013
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
7 Aug 2013
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
9 May 2013
-
Cons. EPS
-
EPS
Amicus Therapeutics Inc. logo
FOLD Amicus Therapeutics Inc.
12 Mar 2013
-
Cons. EPS
-
EPS

FOLD Earnings Reports FAQ

What is the earnings per share (EPS) for FOLD?

The current EPS is -0.45.

What is the company's earnings growth rate?

Amicus Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-18, based on the FOLD's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings were 0.17 per share, reported on 2025-11-05. For dividend history, visit the FOLD Dividends page.

What is the price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio is 58.24, calculated based on the most recent stock price of $9.90.